AbilityPharma logo — Advancing cancer treatment through innovative therapeutics t...

AbilityPharma

Advancing cancer treatment through innovative therapeutics targeting cell membranes.

Founded 2009 Spain Spain 23 employees Venture round Total: $24.33M Biotechnology, Health Care +1

General Information

Company Name AbilityPharma
Founded Year 2009
Location Spain Spain
Employees 23
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with AbilityPharma. To contact AbilityPharma, visit abilitypharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About AbilityPharma

Ability Pharmaceuticals is dedicated to advancing cancer treatment through innovative therapeutics targeting cell membranes. Located in Barcelona, Spain, the company specializes in the discovery and development of novel drugs for cancer and other diseases with unmet medical needs. Their focus lies in creating innovative therapies for lung and pancreatic cancer by leveraging Lipid Analogue Therapeutics. This new class of drugs has the potential to reorganize lipid structures within the cell membrane, leading to the formation of non-lamellar phase structures. Their pipeline includes ABTL0812, currently in preclinical development, and ABTL1014, a drug candidate undergoing preclinical characterization. Founded in 2009, Ability Pharmaceuticals operates in the Biotechnology, Health Care, and Pharmaceutical industries. Its most recent investment was a €7.00M Venture Round on 11 March 2024, with participation from Inveready, CTI Life Sciences Fund, European Innovation Council, Fitalent, CDTI Innovación's INNVIERTE program, GESAMO family office, and IVAMOSA family office. Overall, Ability Pharmaceuticals stands as a promising player in the biotech industry with a focus on pioneering cancer therapeutics.

Taxonomy: Cancer treatment, Therapeutics, Drug discovery, Cell membrane targeting, Lipid Analogue Therapeutics, Innovation, Biopharmaceuticals, Preclinical development, ABTL0812, ABTL1014, Lung cancer, Pancreatic cancer, Unmet medical needs, Barcelona

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €7.00M 7
Inveready, CTI Life Sciences Fund +5
11 Mar 2024
Corporate Round $3.00M 1
SciClone Pharmaceuticals
28 Dec 2020
Equity Crowdfunding €2.00M -
17 Nov 2020
Grant €1.60M 1
U.S. Food and Drug Administration
22 Oct 2020
Grant €5.00M 2
European Innovation Council, Horizon 2020
25 Mar 2020
Venture Round Undisclosed 1
European Innovation Council
08 Jan 2020
Venture Round €3.50M 3
Inveready, Everis Group +1
16 Sep 2019
Equity Crowdfunding €1.23M 1
Capital Cell
04 Dec 2018
Venture Round €1.00M 1
Inveready
19 Sep 2012

AbilityPharma Alternatives & Competitors

View All Alternatives
AbilityPharma vs

Advancing cancer care with innovative solutions to improve patient outcomes

Series E
Biotechnology, Health and Wellness
AbilityPharma vs
Dualyx
Dualyx Belgium

Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare...

Series A
6 employees
Biotechnology, Health Care
AbilityPharma vs

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology

FAQ About AbilityPharma

Advancing cancer treatment through innovative therapeutics targeting cell membranes.
AbilityPharma was founded in 2009.
AbilityPharma is headquartered in Spain.
AbilityPharma operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Cancer treatment, Therapeutics, Drug discovery and Cell membrane targeting.
AbilityPharma has approximately 23 employees.
AbilityPharma has completed 9 funding rounds, raising a total of $24.33M. The latest funding stage is Venture round.
Top alternatives and competitors to AbilityPharma include Gemin X Pharmaceuticals, Dualyx, Prescient Therapeutics, Genmab, Angitia Biopharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AbilityPharma and Gemin X Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AbilityPharma, https://bouncewatch.com/company/ability-pharmaceuticals, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes